Introduction
============

Preterm newborns have increased morbidity and mortality rate due to a lot of factors. The literature describes various reasons including low birth weight, gestational age, and immaturity of the immune system, brain, and other organs, and has analyzed various prenatal conditions that make them more prone to sepsis, organ failure, increased need for intensive care, and even death. Even though many studies have studied each factor separately and in combination, the consensus and the debate are still ongoing.[@b1-tcrm-14-1965]--[@b5-tcrm-14-1965]

Many authors have studied the poor neurodevelopment in correlation to immaturity in preterm newborns focusing on factors that contribute to the occurrence of intraventricular hemorrhage (IVH),[@b1-tcrm-14-1965] but, to our knowledge, evaluation of late-onset neonatal sepsis (LONS) as a predictor for poor outcome in preterm infants with posthemorrhagic hydrocephalus (PHH) has never been investigated, evaluated, or analyzed.

Despite controversies, progress in treatment of preterm newborns has been achieved. In line with the progress, the incidence of IVH and neurological morbidity are decreasing in preterm infants.[@b1-tcrm-14-1965]--[@b3-tcrm-14-1965] PHH occurs in about 35% of the patients with IVH, with approximately 15% of them requiring permanent cerebrospinal fluid (CSF) diversion that can result in complications and death as the final outcome.[@b2-tcrm-14-1965]--[@b8-tcrm-14-1965]

On the other hand, LONS typically occurs after 3 postnatal days and represents an important cause of neurodevelopmental impairment with a mortality rate of 18% in premature infants hospitalized in the neonatal intensive care unit.[@b9-tcrm-14-1965] Epidemiological data on newborns show that the predominant pathogens causing LONS are coagulase-negative staphylococci, followed by Gram-negative bacilli, and fungi. Apart from immaturity, other well-recognized risk factors for LONS include long-term use of invasive interventions, such as mechanical ventilation (MV), intra-vascular catheterization, prolonged parenteral nutrition, hospitalization, surgery, and underlying respiratory and cardiovascular diseases.[@b9-tcrm-14-1965],[@b10-tcrm-14-1965]

Even though preterm newborns with LONS and PHH are at increased risk for morbidity, it is still not clear whether perinatal or postnatal, or combinations of both factors, influence their poor outcome.

The aim of this study was to analyze and evaluate the risk factors associated with poor outcome in preterm neonates with LONS who had PHH and underwent neurosurgical procedures for treatment of the hydrocephalus.

Materials and methods
=====================

Study material and outcome measurements
---------------------------------------

A retrospective review of the medical records of operated preterm newborns (\<35 weeks of gestational age) was performed in the neonatal period (0--28 days old), who had been treated for IVH grade III or IV, at the University Children's Hospital in Belgrade, between December 2005 and December 2015. All patients who were included in the study had been transferred from other medical centers and neonatology units. Patients were divided into two study groups: patients with LONS (diagnosed after birth) and control group which consisted of nonseptic patients (non-LONS group).

In both groups, we analyzed and compared baseline characteristics: gestational age (in weeks), sex, birth weight (in grams), head size (in centimeters), and Apgar score of 1 and 5 minutes. We also collected the information on the presence of preoperative conditions such as 1) preoperatively diagnosed IVH grade III or IV, 2) timing of late-onset sepsis (days from birth), 3) timing of neurosurgery (days from birth), 4) the type of neurosurgical procedure: ventriculoperitoneal (VP) shunt vs Ommaya reservoir, 5) the conversion of Ommaya reservoir to VP shunt, 6) multiple revision (≥2 revisions), 7) duration of hospitalization (days), 8) resuscitation after birth, 9) intubation in the first 3 days of life, 10) high inspiratory concentration of O~2~ in the first 24 hours of life ≥30%, 11) preoperative platelet count (PLT) \<150.000/mL, 12) preoperative use of red blood cell (RBC transfusion), 13) preoperative use of inotropes such as dopamine or dobutamine, 14) MV, 15) MV longer than 7 days, 16) bronchopulmonary dysplasia (BPD), 17) pneumothorax, 18) respiratory distress syndrome (RDS), and 19) ductus arteriosus persistens (DAP).

Additionally, we analyzed the mortality rate in both groups, and subsequently (according to the lethal or nonlethal outcome), we also evaluated previously analyzed factors in respect to whether the lethal or nonlethal outcome was notified.

The exclusion criteria included presence of congenital anomalies, brain atrophy, diffuse cystic encephalomalacia, and spina bifida.

Definitions of procedures, conditions, and analyzed factors
-----------------------------------------------------------

Neurosurgical diagnosis and interventions: The indication for neurosurgery treatment was established after the development of convincing clinical symptoms and signs of elevated intracranial pressure. Clinical symptoms of raised intracranial pressure and PHH were rapidly increasing of head circumference, more than 1 cm/wk, full or tense anterior fontanel, and split sutures confirmed with serial ultrasounds as well as apnea/bradycardia occurrence. IVH was graded according to the Papile classification.[@b11-tcrm-14-1965] Preoperative examination included computed tomography. The Ommaya reservoir or VP shunt were the operative neurosurgical techniques used in these patients. Indication for Ommaya reservoir was body weight of infants \<1,500 g. Indication for VP shunt was body weight more than 1,500 g, tolerant of feeding, no possibility of developing necrotizing enterocolitis, repeated negative CSF microbiological cultures, and CSF protein \<1.5 g/L.[@b7-tcrm-14-1965],[@b8-tcrm-14-1965] Surgery was performed under general anesthesia with the routine administration of prophylactic antibiotic ceftriaxone 100 mg/kg, and the same dose was continued for 5 days after the operation.

LONS was defined as a positive blood or CSF culture after the 3rd postnatal day, accompanied by treatment with antibiotics for at least 5 days (unless death occurred before 5th day of antibiotic treatment).[@b3-tcrm-14-1965],[@b9-tcrm-14-1965] Before the surgical procedure, systemic and intracerebral infections were ruled out by blood tests and using CSF samples.

BPD was defined as oxygen use at 36 weeks postmenstrual age or at discharge/transfer before 36 weeks in infants who survived to 36 weeks.[@b3-tcrm-14-1965]

Pneumothorax was defined as the presence of air in the pleural cavity, diagnosed by chest radiography.

RDS was diagnosed according to the presence of respiratory distress and a characteristic chest radiography.[@b6-tcrm-14-1965]

DAP was defined as the condition in which the ductus arteriosus fails to close after birth, diagnosed by echocardiography.

Metabolic acidosis was defined as a capillary pH value lower than 7.25 with normal pCO~2~ and capillary HCO~3~ values lover than 20.0 mM/L.

The American Society of Anesthesiologists-Physical Status score (ASA-PS) was defined as follows: class I, healthy patients; class II, patients with a mild systemic disease; class III, patients with a severe systemic disease; class IV, patients with severe systemic disease that is a constant threat to life; and class V, a moribund patient not expected to survive 24 hours with or without operation; and class VI, declared brain-dead and organs are being removed for donor purposes ([Figure 1](#f1-tcrm-14-1965){ref-type="fig"}).

Lethal outcome/postoperative death was defined as the lethal outcome that occurred at any time during the hospitalization after completion of the neurosurgical procedure.

Statistical analysis
--------------------

Descriptive measures were presented according to the variable characteristics, ie, the mean and SD for continuous variable and percentage for a categorical variable. Data distribution normality was tested using the coefficient of variation, Q--Q plots, and Kolmogorov--Smirnov test. The differences in means were tested using Student's *t*-test for parametric variables and Mann--Whitney *U* test for nonparametric data. Differences in proportions were tested using chi-squared test or Fisher's exact test. Descriptive measures were presented according to the variable characteristics, ie, mean and SD for parametric variable, the median and interval for nonparametric numeric variable, and percentage for a categorical variable. Statistical analysis was performed using SPSS for Windows (version 17.0, SPSS Inc., Chicago, IL, USA).

Ethical considerations
----------------------

The study was approved by the Medical Faculty University of Belgrade Ethics Committee (No 29/V-14). All procedures performed in the study involving human participants were in accordance with the 1964 Declaration of Helsinki and its later amendments covering patient data confidentiality. The Ethics Committee of the Medical Faculty University of Belgrade waived the need for written informed consent from the patients because the study was retrospective. Data were deidentified to protect the privacy and maintain confidentiality of patient information.

Results
=======

Patient population
------------------

During the 10-year period between December 2005 and December 2015, 97 infants with IVH grade III or IV were operated on at the University Children's Hospital in Belgrade. Out of them, 74 patients met the criteria to be included in the study, with 39 patients with LONS being included in the LONS group and 35 patients in the non-LONS group. Demographic and clinical characteristics of both groups and comparison between the groups are shown in [Figure 2](#f2-tcrm-14-1965){ref-type="fig"}.

Patients and clinical characteristics
-------------------------------------

There was a significant difference between the groups in terms of gender (19 \[70.4%\] girls had LONS vs 20 \[42.6%\] boys, *χ*^2^=5.32, *P*=0.03), gestational age (30.46±3.63 in LONS group vs 32.29±3.1 in the non-LONS group, *t*=2.31, *P*=0.024), head size (28.98±3.1 in LONS group vs 31.37±3.4 in the non-LONS group, *t*=2.78, *P*=0.007), body weight (1,652.56±778.25 in LONS group vs 2,132.14±823.15 in the non-LONS group Mann--Whitney test, *P*=0.005), Apgar score at 5 minutes (5.46±2.1 in LONS group vs 6.66±1.74 in the non-LONS group Mann--Whitney test, *P*=0.070), ASA-PS score (3.26±0.72 in LONS group vs 2.26±0.56 in non-LONS group, *t*=6.63, *P*=0.000), and duration of hospitalization (59.15±45.88 in LONS group vs 33.06±14.55 in non-LONS group Mann--Whitney test, *P*=0.003). The mean time when the LONS was diagnosed was 7.15±2.40 days.

There was no statistically significant difference between the groups in the Apgar score at 1 minute, IVH grade III or IV, timing of neurosurgery, and the type of neurosurgery procedures, ie, Ommaya reservoir or VP shunt. Also, there was no significant difference in the case of conversion of Ommaya reservoir to VP shunt and in the terms of multiple revisions. None of the patients who were included in the study had four or more operations.

A summary of the patients' clinical characteristics is shown in [Table 1](#t1-tcrm-14-1965){ref-type="table"}.

Preoperative clinical, laboratory finding, and conditions within the groups and between the groups
--------------------------------------------------------------------------------------------------

There were statistically significant differences between the groups in terms of high inspiratory concentration of O~2~ in the first 24 hours of life (35 \[89.7%\] in LONS group vs 16 \[45.7%\] in the non-LONS group, *χ*^2^=16.69, *P*=0.000), resuscitation after birth (30 \[76.9%\] in LONS group vs 6 \[17.1%\] in the non-LONS group, *χ*^2^=26.39, *P*=0.000), and intubation in the first 3 days of life (31 \[79.5%\] in LONS group vs 8 \[22.9%\] in the non-LONS group, *χ*^2^=23.73, *P*=0.000) with respect to the groups.

Laboratory and metabolic findings like preoperative low PLT count (28 \[71.8%\] in LONS group vs 6 \[17.1%\] in non-LONS group, *χ*^2^=22.18, *P*=0.000), preoperative metabolic acidosis (30 \[76.9%\] vs 10 \[28.6%\] in non-LONS group, *χ*^2^=17.36, *P*=0.000), and preoperative use of RBC transfusion (30 \[76.9%\] vs 11 \[31.4%\], *χ*^2^=15.45, *P*=0.000), also showed statistically significant differences when assessing the LONS and non-LONS groups.

There were statistically significant differences between the groups concerning preoperative use of inotropes (26 \[66.7%\] in LONS vs 4 \[11.4%\] in non-LONS group, *χ*^2^=23.35, *P*=0.000), MV (31 \[79.5%\] in LONS group vs 12 \[34.3%\] in non-LOS group, *χ*^2^=15.48, *P*=0.000), and MV longer than 7 days (26/31 \[83.9%\] in LONS group vs 3/12 \[25%\] in non-LONS group, *χ*^2^=13.56, *P*=0.001).

Pneumothorax occurred significantly more frequently in the LONS group (6 \[15.4%\] vs 0 \[0%\] than in the non-LONS group, Fisher's exact test, *P*=0.026). There were statistically significant differences between the groups concerning RDS between groups (25 \[64.1%\] in LONS group vs 8 \[22.9%\] in the non-LONS group, *χ*^2^=12.7, *P*=0.000), BPD (6 \[15.4%\] in LONS group vs 0 \[0%\] in the non-LONS group, Fisher's exact test, *P*=0.026), and DAP (14 \[35.9%\] in LONS group vs 0 \[0%\] in the non-LONS group, Fisher's exact test, *P*=0.000). The summarized data reporting the preoperative clinical and laboratory findings and conditions within the groups and between the groups are shown in [Table 2](#t2-tcrm-14-1965){ref-type="table"}. The modes of preoperative MV are shown in [Table 3](#t3-tcrm-14-1965){ref-type="table"}.

Analyses and evaluation in respect to the outcome (lethal or nonlethal)
-----------------------------------------------------------------------

A lethal outcome was found only in 5 (6.76%) patients in the LONS group. Sixty-nine (93.24%) patients had a nonlethal outcome. When we subsequently analyzed and evaluated data according to the lethal or nonlethal outcome, we found out that ASA-PC score 4 (*t*=-3.75, *P*=0.000), pneumothorax (Fisher's exact test, *P*=0.003), BPD (Fisher's exact test, *P*=0.003), and DAP (Fisher's exact test, *P*=0.000) were significantly higher in patients that had lethal outcome.

On the other hand, statistically significant differences for gestational age, gender, head size, body weight, Apgar score in the 1st and 5th min, IVH grade III or IV, the high inspira-tory concentration of O~2~ in the first 24 hours, intubation in the first 3 days of life, resuscitation after birth, LONS, the time when the LONS was diagnosed, time of neurosurgery, MV, MV longer than 7 days, preoperative use of RBC transfusion, preoperative low PLT count, preoperative metabolic acidosis, preoperative use of inotropes, and RDS were not found between the patients with or without lethal outcome. The summarized characteristics of analyzed factors with respect to the outcome are shown in [Tables 4](#t4-tcrm-14-1965){ref-type="table"} and [5](#t5-tcrm-14-1965){ref-type="table"}.

Individual analyses of the patients with lethal outcome
-------------------------------------------------------

There were a total of five postoperative deaths (6.76% of the entire cohort) in our study population, classified as being sepsis-related. Deaths occurring in infants with Gram-negative recurrent LONS accounted for 3/5 (60%). In one patient, death was associated with fungal infection, 1/5 (20%), and in one patient, the cause of lethal outcome was associated with polymicrobial infection, 1/5 (20%). One patient died 14 days after percutaneous endoscopic gastrostomy implantation associated with Gram-negative recurrent LONS. Two patients died 20 days after revision of VP shunt infection and obstruction. In the first patient, VP shunt was initially placed, and in the second patient Ommaya reservoir was indicated as initial treatment. In two patients, postoperative recovery was complicated with recurrent LONS associated with ventilator-associated pneumonia; they died 27 and 42 days after the operation, respectively. All patients who died were mechanically ventilated.

Gram-negative, polymicrobial, and fungal microorganisms that had caused recurrent LONS episodes, shunt infections, and obstructions, combined with prolonged MV, significantly and independently increased the likelihood of postoperative death.

Discussion
==========

Our retrospective study evaluated and analyzed different factors that may be correlated with the poor outcome in patients with LONS who underwent neurosurgical treatment for PHH.

Literature is decisive that the early neonatal period, which lasts from birth to the 7th day of life, is the most dangerous period for a neonate, with an increased risk of morbidity and mortality, including prematurity, IVH, and complications of infections.[@b3-tcrm-14-1965]--[@b5-tcrm-14-1965] In previous studies, authors reported a decrease in mortality rate in preterm neonates, but they emphasized the high risk of subsequent adverse neurodevelopmental outcomes in the survivors of IVH, and sequelae that frequently involved reduced developmental quotient, epilepsy, cerebral palsy, and cognitive impairment.[@b5-tcrm-14-1965],[@b12-tcrm-14-1965]--[@b14-tcrm-14-1965]

Based on our 10-year experience, we did not have lethal outcomes in nonseptic patients who had undergone neurosurgery for PHH. The results in our study considering mortality seem to be logical since sepsis by itself is an enormous factor that leads to a lethal outcome. Several studies have also elaborated the epidemiological, clinical, and microbiological characteristics of patients with LONS and have confirmed that the low birth weight, gestational age, and immaturity of the immune system, may be additional factors that contribute to the lethal outcome in patients with LONS.[@b1-tcrm-14-1965]--[@b5-tcrm-14-1965],[@b9-tcrm-14-1965],[@b10-tcrm-14-1965],[@b15-tcrm-14-1965],[@b16-tcrm-14-1965]

Similarly, but using the different methodology in the present study, we showed that the patients with LONS were sicker, which could explain association of LONS in preterm neonates with lethal outcome. In the LONS group, patients had lower gestational age, head size, body weight, lower Apgar score at 5 minutes, longer hospital stay, and higher preoperative ASA-PS score than patient without sepsis, similar to the previous studies.[@b3-tcrm-14-1965],[@b5-tcrm-14-1965],[@b6-tcrm-14-1965],[@b13-tcrm-14-1965]--[@b16-tcrm-14-1965]

Also in the present study, infants with LONS had higher incidence of preoperative comorbidities like BPD, RDS, DAP, metabolic acidosis, low PLT counts, and pneumothorax; this is in line with the results described in the previous studies which found a relationship with lethal outcome.[@b3-tcrm-14-1965],[@b5-tcrm-14-1965],[@b6-tcrm-14-1965],[@b15-tcrm-14-1965] Preterm infants with LONS required longer MV support and more often received preoperative transfusion and inotropes.[@b5-tcrm-14-1965],[@b13-tcrm-14-1965],[@b16-tcrm-14-1965]

The present study does not suggest that the type or timing of surgical intervention and grade III or IV are significant predictors of lethal outcome. Also, in the present study there was no statistically significant difference in case of conversion of Ommaya reservoir to VP shunt and in the terms of multiple revisions in both groups, which is in correlation with the results of other authors.[@b7-tcrm-14-1965],[@b8-tcrm-14-1965]

We showed that preoperative ASA-PS score 4, pneumothorax, DAP, and BPD were strongly associated with lethal outcome in patients with LONS.

Although a number of authors have indicated that pneumothorax increased the degree of IVH, an association of pneumothorax with the frequency of IVH was not found.[@b8-tcrm-14-1965],[@b17-tcrm-14-1965]--[@b25-tcrm-14-1965] We found out that pneumothorax was strongly associated with mortality in operated newborns with PHH, which was not been described in the literature.

BPD is the most common chronic lung disease affecting preterm infants, and the incidence of BPD is inversely related to gestational age. It is associated with growth, health, and neurodevelopmental problems during childhood. According to the literature data, many authors have indicated BPD as a risk factor for IVH.[@b2-tcrm-14-1965],[@b26-tcrm-14-1965]--[@b30-tcrm-14-1965] The results of our study showed that BPD was a significant risk factor associated with lethal outcome in preterm infants, which, to our knowledge, has not yet been reported in the literature.

A patent ductus arteriosus in the first 3 days of life is a physiological shunt in healthy infants, but in preterm infants, it can have significant clinical consequences. More than 50% of preterm infants \<28 weeks gestation receive medical or surgical therapy for DAP to prevent respiratory decompensation, heart failure, IVH, and brain injury.[@b30-tcrm-14-1965] Women who take nonselective cyclooxygenase inhibitors such as indometacin prenatally, as well as tocolysis for preterm labor, are more likely to have an infant with DAP. In previous reports, the association between DAP and IVH was described, but the association between DAP and lethal outcome was not reported.[@b2-tcrm-14-1965],[@b27-tcrm-14-1965],[@b31-tcrm-14-1965]--[@b34-tcrm-14-1965] In contrast, the positive correlation between DAP and lethal outcome was found in our study.

Multiple factors contribute to the risk of developing LONS, including invasive procedures and devices, lack of enteral feeding, and prolonged hospitalization. Different strategies for preventing hospital-acquired LONS include rigorous hand hygiene procedures, skin care, human milk feeding, discontinuing invasive devices when not needed, and standardization of processes related to central line care with central bundles. All preventive measures described above are important cost-effective strategies for reducing the frequency of LONS.[@b3-tcrm-14-1965]--[@b6-tcrm-14-1965],[@b9-tcrm-14-1965],[@b10-tcrm-14-1965],[@b35-tcrm-14-1965]--[@b39-tcrm-14-1965]

In the present study, the association of recurrent LONS with lethal outcome after the operation may be explained as a result of existing postoperative comorbidities associated with unfavorable outcomes. Gram-negative, polymicrobial, and fungal infections, shunt infections, and obstructions could lead to prolonged MV and development of complications.[@b3-tcrm-14-1965]--[@b8-tcrm-14-1965],[@b40-tcrm-14-1965]--[@b44-tcrm-14-1965]

Limitations of the study
========================

The most significant limitation of this study is that it was a retrospective study from a single medical center, and not a prospective multicenter trial. Another significant limitation is that the small changes of investigated parameters of patients who died significantly changed the statistical result, which decreased the power of this study. Death was a multifactorial endpoint, and despite best efforts, any statistical analysis of postoperative contributing factors cannot be applied in such a small sample.

Conclusion
==========

Neurosurgical procedures are relatively safe in neonates with PHH without LONS after birth. However, if LONS is present, various conditions such as preoperative high grade of ASA score, DAP, BPD, and pneumothorax markedly increase the risk for a lethal outcome after operation. Further studies are warranted to establish the causality of this association.
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###### 

Patient characteristics

  Characteristics                     Overall, n=74           LONS, n=39              Non-LONS, n=35          *P*-value
  ----------------------------------- ----------------------- ----------------------- ----------------------- -----------
                                                                                                              
  Gender                              47 m/27 f               20 m/19 f               27 m/8 f                0.03
  Gestational age                     31.32±3.49              30.46±3.63              32.29±3.1               0.024
  Head size                           30.11±3.85              28.98±3.1               31.37±3.4               0.007
  Body weight                         1,879.39±830.05         1,652.56±778.25         2,132.14±823.15         0.005
  Apgar score at 1 minute             5.26±2.07               4.85±1.98               5.71±2.09               0.071
  Apgar score at 5 minutes            6.03±2.02               5.46±2.1                6.66±1.74               0.070
  IVH grade III/IVH grade IV          30 (40.5%)/34 (59.5%)   17 (43.6%)/22 (56.4%)   13 (37.1%)/22 (62.9%)   0.639
  ASA-PS score                        2.78±0.82               3.26±0.72               2.26±0.56               0.000
  Timing of late-onset sepsis         7.15±2.40               7.15±2.40                                       
  Timing of neurosurgery              23.23±5.78              23.49±5.53              22.94±6.11              0.689
  VP shunt/Ommaya reservoir           44 (59.5%)/30 (40.5%)   21 (53.8%)/18 (46.2%)   23 (65.7%)/12 (34.3%)   0.212
  Conversion of Ommaya to VP shunt    14 (18.92%)             7 (38.9%)               7 (58.3%)               0.822
  Multiple revisions (≥2 revisions)   7 (9.46%)               4 (10.26%)              3 (8.57%)               0.805
  Duration of hospitalization         46.81±36.96             59.15±45.88             33.06±14.55             0.003
  33 (8--210)                         42 (12--210)            29 (8--65)                                      

**Abbreviations:** ASA-PS, The American Society of Anesthesiologists-Physical Status; IVH, intraventricular hemorrhage; LONS, late-onset neonatal sepsis; VP, ventriculoperitoneal.

###### 

The presence of preoperative conditions

  Characteristics                                       Overall,       LONS,          Non-LONS,   *P*-value
  ----------------------------------------------------- -------------- -------------- ----------- -----------
                                                                                                  
  High inspiratory O~2~ in the first 24 hours of life   51 (68.9)      35 (89.7)      16 (45.7)   0.000
  Resuscitation after birth                             36 (48.6)      30 (76.9)      6 (17.1)    0.000
  Intubation in the first 3 days of life                39 (52.7)      31 (79.5)      8 (22.9)    0.000
  Preoperative low P LT count                           34 (45.9)      28 (71.8)      6 (17.1)    0.000
  Preoperative metabolic acidosis                       40 (54.1)      30 (76.9)      10 (28.6)   0.000
  Preoperative RBC transfusion                          41 (55.4)      30 (76.9)      11 (31.4)   0.000
  Preoperative use of inotropes                         30 (40.5)      26 (66.7)      4 (11.4)    0.000
  MV                                                    43 (58.1)      31 (79.5)      12 (34.3)   0.000
  MV longer than 7 days                                 29/43 (67.4)   26/31 (83.9)   3/12 (25)   0.001
  Pneumothorax                                          6 (8.1)        6 (15.4)       0 (0)       0.026
  RDS                                                   33 (44.6)      25 (64.1)      8 (22.9)    0.000
  BPD                                                   6 (8.1)        6 (15.4)       0 (0)       0.026
  DAP                                                   14 (18.9)      14 (35.9)      0 (0)       0.000

**Abbreviations:** BPD, bronchopulmonary dysplasia; DAP, ductus arteriosus persistens; LONS, late-onset neonatal sepsis; MV, mechanical ventilation; PLT, platelets; RBC, red blood cell; RDS, respiratory distress syndrome.

###### 

The modes of preoperative MV

                        Overall, n = 74 (%)   LONS, n = 39 (%)   Non-LONS, n = 35 (%)   Deceased, n = 5 (%)
  --------------------- --------------------- ------------------ ---------------------- ---------------------
                                                                                        
  Nasal CPAP            5 (6.8)               1 (2.6)            4 (11.4)               0
  MV (conventional)     36 (48.6)             28 (71.8)          8 (22.9)               5 (100)
  MV (high-frequency)   2 (2.7)               2 (5.1)            0                      0
  Total                 43 (58.1)             31 (79.5)          12 (34.3)              5 (100)

**Abbreviations:** CPAP, continuous positive airway pressure; LONS, late-onset neonatal sepsis; MV, mechanical ventilation.

###### 

Predictors of lethal outcome

  Characteristics                               Deceased, n = 5   Control group, n = 69   *P*-value
  --------------------------------------------- ----------------- ----------------------- -----------
                                                                                          
  Gender                                        4 m/1 f           42 m/26 f               0.647
  Head size                                     30.00±2.45        30.12±3.95              0.947
  Gestational age                               32.20±4.02        31.26±3.47              0.565
  Body weight (g)                               2,200.00±899.30   1,856.16±827.02         0.425
  Apgar score of 1 minute                       6.00±2.74         5.2±2.02                0.409
  Apgar score of 5 minutes                      6.80±1.79         5.97±2.04               0.502
  IVH grade III/IVH grade                       0/100%            43.5%/56.5%             0.076
  ASA-PC score                                  4                 2.70±0.77               0.000
  High inspiratory O~2~ in the first 24 hours   5 (100%)          46 (66.7%)              0.316
  Intubation in the first 3 days of life        5 (100%)          34 (49.3%)              0.056
  Resuscitation after birth                     5 (100%)          31 (44.9%)              0.023
  LONS                                          5 (100%)          34 (49.3%)              0.056
  Time of late-onset sepsis                     6.00±2.34         7.32±2.39               0.29
  Time of neurosurgery                          21.80±6.72        23.33±5.74              0.57
  MV                                            5 (100%)          38 (55.1)               0.07
  MV longer than 7 days                         5/5 (100%)        24/38 (63.2%)           0.156
  Preoperative low P LT count                   5 (100%)          29 (42%)                0.17
  Preoperative metabolic acidosis               5 (100%)          35 (50.7%)              0.058
  Preoperative RBC transfusion                  5 (100%)          36 (52.2%)              0.061
  Preoperative use of inotropes                 5 (100%)          25 (36.2%)              0.009
  Pneumothorax                                  3 (60%)           3 (4.3%)                0.003
  RDS                                           5 (100%)          28 (40.6%)              0.015
  BPD                                           3 (60%)           3 (4.3%)                0.003
  DAP                                           5 (100%)          9 (13%)                 0.000

**Abbreviations:** ASA-PC, The American Society of Anesthesiologists-Physical Status; BPD, bronchopulmonary dysplasia; DAP, ductus arteriosus persistens; IVH, intraventricular hemorrhage; LONS, late-onset neonatal sepsis; MV, mechanical ventilation; RBC, red blood cell; RDS, respiratory distress syndrome.

###### 

Risk factors associated with lethal outcome used in the multivariable stepwise logistic regression analysis

  Variables      OR     95% CI       *P*-value
  -------------- ------ ------------ ------------
                                     
  DAP            1.27   1.13--1.42   *P*\<0.001
  Pneumothorax   1.37   1.17--1.61   *P*\<0.001
  BPD            1.29   1.10--1.53   *P*=0.003

**Abbreviations:** BPD, bronchopulmonary dysplasia; DAP, ductus arteriosus persistens.
